Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT

Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.

BACKGROUND AND OBJECTIVES Increased visit-to-visit variability of BP is associated with cardiovascular disease risk. We examined the association of visit-to-visit variability of BP with renal outcomes among 21,245 participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS We measured mean BP and visit-to-visit...

Visit-to-Visit Blood Pressure Variability

One of the most interesting findings of hypertension research in the past 10 years has been that the cardiovascular protective effects of antihypertensive drugs depend not only on the mean blood pressure (BP) values achieved during treatment but also on the consistency of BP control between on-treatment visits. This was suggested in 2007 by the observation that in patients with hypertension and...

Visit-to-Visit Blood Pressure Variability

One of the most interesting findings of hypertension research in the past 10 years has been that the cardiovascular protective effects of antihypertensive drugs depend not only on the mean blood pressure (BP) values achieved during treatment but also on the consistency of BP control between on-treatment visits. This was suggested in 2007 by the observation that in patients with hypertension and...

Treating Visit-to-Visit Blood Pressure Variability to Improve Prognosis

Blood pressure (BP) levels are linearly associated with cardiovascular risk, and hypertension is the most common modifiable risk factor for cardiovascular disease. Moreover, antihypertensive treatment-induced BP lowering has been associated with reduction in all outcomes (stroke, heart failure, coronary events, cardiovascular, and all-cause mortality). Apart from the established knowledge regar...

The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure